This list is an analysis based on recent market events. It's not an investment recommendation.
About
Zhengye Biotechnology Holding Ltd is engaged in research, development, manufacturing, and sales of veterinary vaccines, with an emphasis on vaccines for livestock. It has a diverse range of vaccines, including vaccines for swine, cattle, goats, waterfowl, sheep, poultry, and pets, available in various provincial regions across China and are exported overseas to Vietnam, Pakistan, and Egypt. The company generates maximum revenue from the sale of swine vaccines, followed by poultry and other vaccines.
The current price of ZYBT is $1.25 USD — it has decreased by -3.85% in the past 24 hours. Watch Zhengye Biotechnology stock price performance more closely on the chart.
What is Zhengye Biotechnology stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Zhengye Biotechnology stocks are traded under the ticker ZYBT.
Is Zhengye Biotechnology stock price growing?▼
ZYBT stock has fallen by -11.97% compared to the previous week, the month change is a +0.81% rise, over the last year Zhengye Biotechnology has showed a -49.19% decrease.
What is Zhengye Biotechnology market cap?▼
Today Zhengye Biotechnology has the market capitalization of 59.24M
What is Zhengye Biotechnology revenue for the last year?▼
Zhengye Biotechnology revenue for the last year amounts to 16.42M USD.
What is Zhengye Biotechnology net income for the last year?▼
ZYBT net income for the last year is -9.9M USD.
How many employees does Zhengye Biotechnology have?▼
As of November 2, 2026, the company has 269 employees.
In which sector is Zhengye Biotechnology located?▼
Zhengye Biotechnology operates in the Health & Wellness sector.
When did Zhengye Biotechnology complete a stock split?▼
Zhengye Biotechnology has not had any recent stock splits.
Where is Zhengye Biotechnology headquartered?▼
Zhengye Biotechnology is headquartered in Jilin, Cayman Islands.